Tumor Embolization Market contains market size and forecasts of Tumor Embolization in Global, including the following market information:
- Global Tumor Embolization Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global top five companies in 2021 (%)
The global Tumor Embolization market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
- The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
- Trans-Arterial Embolization (TAE) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
- The global key manufacturers of Tumor Embolization include Boston Scientific Corporation, Varian Medical Systems, Inc., Nordion (Sotera Health) and Sirtex Medical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
- We surveyed the Tumor Embolization companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Tumor Embolization Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Tumor Embolization Market Segment Percentages, by Type, 2021 (%)
- Trans-Arterial Embolization (TAE)
- Drug-Eluting Bead Chemoembolization (DEB-TACE)
- Radioembolization (RE)
- Others
Global Tumor Embolization Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Tumor Embolization Market Segment Percentages, by Application, 2021 (%)
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
- Others
Global Tumor Embolization Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Tumor Embolization Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Tumor Embolization revenues in global market, 2017-2022 (estimated), ($ millions)
- Key companies Tumor Embolization revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Boston Scientific Corporation
- Varian Medical Systems, Inc.
- Nordion (Sotera Health)
- Sirtex Medical
Industry Market Size
